Source: Health Canada shortage reports · Updated Jul 9, 2026
Epirubicin products have been discontinued in Canada. See the reports below for which products and when.
A chemotherapy medication (anthracycline) used to treat several types of cancer.
Products affected
0 / 3
Reports on file
18
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
EPIRUBICIN FOR INJECTION
2MG · SOLUTION · TEVA CANADA LIMITED
DIN 02324091 · ended Nov 25, 2025 · Disruption of the manufacture of the drug.
Resolved
EPIRUBICIN FOR INJECTION
2MG · SOLUTION · TEVA CANADA LIMITED
DIN 02324091 · ended Jan 17, 2025 · Disruption of the manufacture of the drug.
Resolved
EPIRUBICIN FOR INJECTION
2MG · SOLUTION · TEVA CANADA LIMITED
DIN 02324091 · ended Nov 29, 2023 · Disruption of the manufacture of the drug.
Resolved
EPIRUBICIN FOR INJECTION
2MG · SOLUTION · TEVA CANADA LIMITED
DIN 02324091 · ended Sep 30, 2023 · Disruption of the manufacture of the drug.
Resolved
EPIRUBICIN FOR INJECTION
2MG · SOLUTION · TEVA CANADA LIMITED
DIN 02324091 · ended Jul 4, 2023 · Disruption of the manufacture of the drug.
Resolved
EPIRUBICIN FOR INJECTION
2MG · SOLUTION · TEVA CANADA LIMITED
DIN 02324091 · ended Apr 27, 2023 · Disruption of the manufacture of the drug.
Discontinued
PMS-EPIRUBICIN
2MG · SOLUTION · PHARMASCIENCE INC
DIN 02410400
Discontinued
PMS-EPIRUBICIN
2MG · SOLUTION · PHARMASCIENCE INC
DIN 02410400
Discontinued
PMS-EPIRUBICIN
2MG · SOLUTION · PHARMASCIENCE INC
DIN 02410400
Resolved
EPIRUBICIN FOR INJECTION
2MG · SOLUTION · TEVA CANADA LIMITED
DIN 02324091 · ended Mar 10, 2021 · Disruption of the manufacture of the drug.
Discontinued
EPIRUBICIN FOR INJECTION
2MG · SOLUTION · TEVA CANADA LIMITED
DIN 02324091
Resolved
EPIRUBICIN FOR INJECTION
2MG · SOLUTION · TEVA CANADA LIMITED
DIN 02324091 · ended Oct 23, 2019 · Disruption of the manufacture of the drug.
Showing 12 of 18 reports. All reports are on file with Health Canada.
What's happening
One or more Epirubicin products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.
Epirubicin is classified under “CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES” (ATC L01DB).
Recent changes
No changes recorded yet.
Common questions
What is Epirubicin used for?
A chemotherapy medication (anthracycline) used to treat several types of cancer.
When will Epirubicin be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Epirubicin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.